InMed Pharmaceuticals Inc (NASDAQ:INM) does about 93.98K shares in volume on a normal day but saw 74230119 shares change hands in the recent trading day. The company now has a market cap of 4.13M USD. Its current market price is $3.42, marking an increase of 37.35% compared to the previous close of $2.49. The 52 week high reached by this stock is $15.70 whilst the lowest price level in 52 weeks is $1.72.
The consensus objective for the share price is $400.00, suggesting that the stock has a potential upside of 99.14% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Hold the stock.
The current price level is 23.79%, 27.71%, and -15.78% away from its SMA20, SMA50, and SMA200 respectively, with the INM price moving below the 50-day SMA on current market day. InMed Pharmaceuticals Inc (INM) stock is up 23.91% over the week and 10.68% over the past month. Its price is -27.85% year-to-date and -38.93% over the past year.
To reach the target analysts have set, the stock logically needs to grow 99.14 percent from here.
Outstanding shares total 1.21M with insiders holding 1.45% of the shares and institutional holders owning 10.18% of the company’s common stock. The company has a return on investment of -111.70% and return on equity of -91.71%. The beta has a value of 0.27. Price to book ratio is 0.59 and price to sales ratio is 0.84.
